Drug Profile
Research programme: selective 5-HT1B/D antagonists and inverse agonists - Pfizer
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class Piperazines
- Mechanism of Action Serotonin 1B receptor antagonists; Serotonin 1B receptor inverse agonists; Serotonin 1D receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Major depressive disorder in USA (PO)
- 17 Apr 2008 Early research in Depression in USA (PO)